aTYR PHARMA INC Weighted Average Number of Shares Outstanding, Basic and Diluted
aTYR PHARMA INC (ATYR) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 27.82 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-10
- aTYR PHARMA INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 27.82M shares, a 97.24% increase year-over-year.
- aTYR PHARMA INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 27.89M shares, a 159.61% increase year-over-year.
- aTYR PHARMA INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 18.16M shares, a 88.21% increase year-over-year.
- aTYR PHARMA INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 16.13M shares, a 72.36% increase year-over-year.
- aTYR PHARMA INC weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 19.08M shares, a 108.30% increase from fiscal 2020.
- aTYR PHARMA INC weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 9.16M shares, a 172.98% increase from fiscal 2019.
- aTYR PHARMA INC weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 3.36M shares, a 56.66% increase from fiscal 2018.
- aTYR PHARMA INC weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 2.14M shares, a 16.09% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 27.82M shares 10-Q · filed 2022-05-10 | 27.85M shares derived: average of 2 quarters · filed 2022-05-10 | 24.62M shares derived: average of 3 quarters · filed 2022-05-10 | 22.50M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2021-12-31 | 27.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 23.02M shares derived: average of 2 quarters · filed 2022-03-15 | 20.73M shares derived: average of 3 quarters · filed 2022-03-15 | 19.08M shares 10-K · filed 2022-03-15 | ||||
| 2021-09-30 | 18.16M shares 10-Q · filed 2021-11-12 | 17.14M shares derived: average of 2 quarters · filed 2021-11-12 | 16.15M shares 10-Q · filed 2021-11-12 | 14.78M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2021-06-30 | 16.13M shares 10-Q · filed 2021-08-11 | 15.12M shares 10-Q · filed 2021-08-11 | 13.66M shares derived: average of 3 quarters · filed 2022-05-10 | 12.66M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2021-03-31 | 14.10M shares 10-Q · filed 2022-05-10 | 12.42M shares derived: average of 2 quarters · filed 2022-05-10 | 11.50M shares derived: average of 3 quarters · filed 2022-05-10 | 10.96M shares derived: average of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | 10.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 10.20M shares derived: average of 2 quarters · filed 2022-03-15 | 9.92M shares derived: average of 3 quarters · filed 2022-03-15 | 9.16M shares 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | 9.65M shares 10-Q · filed 2021-11-12 | 9.50M shares derived: average of 2 quarters · filed 2021-11-12 | 8.63M shares 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | 9.36M shares 10-Q · filed 2021-08-11 | 8.12M shares 10-Q · filed 2021-08-11 | ||||||
| 2019-12-31 | 3.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 3.87M shares derived: average of 2 quarters · filed 2022-03-15 | 3.66M shares derived: average of 3 quarters · filed 2022-03-15 | 3.36M shares 10-K · filed 2022-03-15 | ||||
| 2019-09-30 | 3.85M shares 10-Q · filed 2020-11-13 | 3.55M shares derived: average of 2 quarters · filed 2020-11-13 | 3.18M shares 10-Q · filed 2020-11-13 | 10.77M shares derived: average of 4 quarters · filed 2021-03-24 | ||||
| 2019-06-30 | 3.24M shares 10-Q · filed 2020-08-13 | 2.83M shares 10-Q · filed 2020-08-13 | 13.08M shares derived: average of 3 quarters · filed 2021-03-24 | 10.34M shares derived: average of 4 quarters · filed 2021-03-24 | ||||
| 2019-03-31 | 33.82M shares 10-Q · filed 2019-05-14 | 18.00M shares derived: average of 2 quarters · filed 2021-03-24 | 12.71M shares derived: average of 3 quarters · filed 2021-03-24 | 10.07M shares derived: average of 4 quarters · filed 2021-03-24 | ||||
| 2018-12-31 | 2.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | 2.15M shares derived: average of 2 quarters · filed 2021-03-24 | 2.15M shares derived: average of 3 quarters · filed 2021-03-24 | 2.14M shares 10-K · filed 2021-03-24 | 29.96M shares 10-K · filed 2019-03-26 | |||
| 2018-09-30 | 2.13M shares 10-Q · filed 2019-11-14 | 29.86M shares 10-Q · filed 2018-11-14 | 2.13M shares derived: average of 2 quarters · filed 2019-11-14 | 2.13M shares 10-Q · filed 2019-11-14 | 29.83M shares 10-Q · filed 2018-11-14 | -7.99M shares derived: average of 4 quarters · filed 2020-03-26 | ||
| 2018-06-30 | 2.13M shares 10-Q · filed 2019-08-14 | 29.84M shares 10-Q · filed 2018-08-14 | 2.13M shares 10-Q · filed 2019-08-14 | 29.82M shares 10-Q · filed 2018-08-14 | -11.36M shares derived: average of 3 quarters · filed 2020-03-26 | -2.07M shares derived: average of 4 quarters · filed 2020-03-26 | ||
| 2018-03-31 | 29.80M shares 10-Q · filed 2019-05-14 | -18.11M shares derived: average of 2 quarters · filed 2020-03-26 | -3.46M shares derived: average of 3 quarters · filed 2020-03-26 | 3.35M shares derived: average of 4 quarters · filed 2020-03-26 | ||||
| 2017-12-31 | -66.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -20.10M shares derived: average of 2 quarters · filed 2020-03-26 | -5.46M shares derived: average of 3 quarters · filed 2020-03-26 | 1.85M shares 10-K · filed 2020-03-26 | 25.80M shares 10-K · filed 2018-03-20 | |||
| 2017-09-30 | 25.82M shares 10-Q · filed 2018-11-14 | 24.81M shares derived: average of 2 quarters · filed 2018-11-14 | 24.46M shares 10-Q · filed 2018-11-14 | 24.27M shares derived: average of 4 quarters · filed 2019-03-26 | ||||
| 2017-06-30 | 23.81M shares 10-Q · filed 2018-08-14 | 23.77M shares 10-Q · filed 2018-08-14 | 23.76M shares derived: average of 3 quarters · filed 2019-03-26 | 23.74M shares derived: average of 4 quarters · filed 2019-03-26 | ||||
| 2017-03-31 | 23.74M shares 10-Q · filed 2018-05-15 | 23.73M shares derived: average of 2 quarters · filed 2019-03-26 | 23.72M shares derived: average of 3 quarters · filed 2019-03-26 | 23.71M shares derived: average of 4 quarters · filed 2019-03-26 | ||||
| 2016-12-31 | 23.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | 23.71M shares derived: average of 2 quarters · filed 2019-03-26 | 23.70M shares derived: average of 3 quarters · filed 2019-03-26 | 23.68M shares 10-K · filed 2019-03-26 | ||||
| 2016-09-30 | 23.70M shares 10-Q · filed 2017-11-14 | 23.68M shares derived: average of 2 quarters · filed 2017-11-14 | 23.67M shares 10-Q · filed 2017-11-14 | 23.67M shares derived: average of 4 quarters · filed 2018-03-20 | ||||
| 2016-06-30 | 23.67M shares 10-Q · filed 2017-08-14 | 23.66M shares 10-Q · filed 2017-08-14 | 23.66M shares derived: average of 3 quarters · filed 2018-03-20 | 23.64M shares derived: average of 4 quarters · filed 2018-03-20 | ||||
| 2016-03-31 | 23.63M shares 10-Q · filed 2017-05-11 | 23.66M shares derived: average of 2 quarters · filed 2018-03-20 | 23.63M shares derived: average of 3 quarters · filed 2018-03-20 | 21.45M shares derived: average of 4 quarters · filed 2018-03-20 | ||||
| 2015-12-31 | 23.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | 23.63M shares derived: average of 2 quarters · filed 2018-03-20 | 20.72M shares derived: average of 3 quarters · filed 2018-03-20 | 15.84M shares 10-K · filed 2018-03-20 | ||||
| 2015-09-30 | 23.58M shares 10-Q · filed 2016-11-14 | 19.24M shares derived: average of 2 quarters · filed 2016-11-14 | 13.22M shares 10-Q · filed 2016-11-14 | 10.08M shares derived: average of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | 14.90M shares 10-Q · filed 2016-08-10 | 7.96M shares 10-Q · filed 2016-08-10 | 5.58M shares derived: average of 3 quarters · filed 2017-03-16 | 4.39M shares derived: average of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | 966.32K shares 10-Q · filed 2016-05-11 | 915.51K shares derived: average of 2 quarters · filed 2017-03-16 | 891.61K shares derived: average of 3 quarters · filed 2017-03-16 | 877.84K shares derived: average of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | 864.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 854.26K shares derived: average of 2 quarters · filed 2017-03-16 | 848.35K shares derived: average of 3 quarters · filed 2017-03-16 | 834.22K shares 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | 843.82K shares 10-Q · filed 2015-11-10 | 840.17K shares derived: average of 2 quarters · filed 2015-11-10 | 824.06K shares 10-Q · filed 2015-11-10 | |||||
| 2014-06-30 | 836.53K shares 10-Q · filed 2015-08-12 | 814.03K shares 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | 791.28K shares 10-Q · filed 2015-06-18 | |||||||
| 2013-12-31 | 762.76K shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |